Your browser doesn't support javascript.
Factors predicting in-hospital all-cause mortality in COVID 19 patients at the Laquintinie Hospital Douala, Cameroon.
Ebongue, Marie Solange Ndom; Lemogoum, Daniel; Endale-Mangamba, Laurent Mireille; Barche, Blaise; Eyoum, Christian; Simo Yomi, Styve Hermane; Mekolo, David; Ngambi, Vincent; Doumbe, Jacques; Sike, Christiane Medi; Boombhi, Jerome; Ngondi, Grace; Biholong, Christian; Kamdem, Josephine; Mbenoun, Liliane; Tegeu, Calixthe Kuaté; Djomou, Armel; Dzudie, Anastase; Kamdem, Felicité; Ntock, Ferdinand Ndom; Mfeukeu, Liliane Kuaté; Sobngwi, Eugène; Penda, Ida; Njock, Richard; Essomba, Noel; Yombi, Jean Cyr; Ngatchou, William.
  • Ebongue MSN; COVID-19 Working Group, Laquintinie Hospital, Douala, Cameroon; Department of Medicine and Specialities, Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Cameroon.
  • Lemogoum D; COVID-19 Working Group, Laquintinie Hospital, Douala, Cameroon; Department of Medicine and Specialities, Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Cameroon.
  • Endale-Mangamba LM; COVID-19 Working Group, Laquintinie Hospital, Douala, Cameroon; Department of Medicine and Specialities, Faculty of Health Sciences, University of Buea, Cameroon.
  • Barche B; COVID-19 Working Group, Laquintinie Hospital, Douala, Cameroon; Department of Anaesthesiology and Reanimation Laquintinie Hospital, Douala, Cameroon.
  • Eyoum C; COVID-19 Working Group, Laquintinie Hospital, Douala, Cameroon; Department of Psychology, Faculty of Health Sciences, University of Douala, Cameroon.
  • Simo Yomi SH; COVID-19 Working Group, Laquintinie Hospital, Douala, Cameroon.
  • Mekolo D; COVID-19 Working Group, Laquintinie Hospital, Douala, Cameroon; Department of Anaesthesiology and Reanimation Laquintinie Hospital, Douala, Cameroon.
  • Ngambi V; COVID-19 Working Group, Laquintinie Hospital, Douala, Cameroon.
  • Doumbe J; COVID-19 Working Group, Laquintinie Hospital, Douala, Cameroon; Department of Medicine and Specialities, Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Cameroon.
  • Sike CM; COVID-19 Working Group, Laquintinie Hospital, Douala, Cameroon.
  • Boombhi J; COVID-19 Working Group, Laquintinie Hospital, Douala, Cameroon; Department of Medicine and Specialities, Faculty of Medicine and Biomedical Sciences, University of Yaounde, Cameroon.
  • Ngondi G; COVID-19 Working Group, Laquintinie Hospital, Douala, Cameroon; Department of Biology Laquintinie Hospital, Douala, Cameroon.
  • Biholong C; COVID-19 Working Group, Laquintinie Hospital, Douala, Cameroon.
  • Kamdem J; COVID-19 Working Group, Laquintinie Hospital, Douala, Cameroon.
  • Mbenoun L; COVID-19 Working Group, Laquintinie Hospital, Douala, Cameroon.
  • Tegeu CK; COVID-19 Working Group, Laquintinie Hospital, Douala, Cameroon; Department of Medicine and Specialities, Faculty of Medicine and Biomedical Sciences, University of Yaounde, Cameroon.
  • Djomou A; COVID-19 Working Group, Laquintinie Hospital, Douala, Cameroon.
  • Dzudie A; COVID-19 Working Group, Laquintinie Hospital, Douala, Cameroon; Department of Cardiology General Hospital, Douala, Cameroon.
  • Kamdem F; COVID-19 Working Group, Laquintinie Hospital, Douala, Cameroon; Department of Cardiology General Hospital, Douala, Cameroon.
  • Ntock FN; COVID-19 Working Group, Laquintinie Hospital, Douala, Cameroon; Department of Surgery and Specialities, Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Cameroon.
  • Mfeukeu LK; COVID-19 Working Group, Laquintinie Hospital, Douala, Cameroon; Department of Medicine and Specialities, Faculty of Medicine and Biomedical Sciences, University of Yaounde, Cameroon.
  • Sobngwi E; COVID-19 Working Group, Laquintinie Hospital, Douala, Cameroon; Department of Medicine and Specialities, Faculty of Medicine and Biomedical Sciences, University of Yaounde, Cameroon.
  • Penda I; Department of Medicine and Specialities, Faculty of Medicine and Biomedical Sciences, University of Yaounde, Cameroon.
  • Njock R; COVID-19 Working Group, Laquintinie Hospital, Douala, Cameroon; Department of Surgery and Specialities, Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Cameroon.
  • Essomba N; COVID-19 Working Group, Laquintinie Hospital, Douala, Cameroon; Department of Public Health, Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Cameroon.
  • Yombi JC; Department of Infectious Diseases Saint Luc University Hospital, Université Catholique de Louvain, B, Belgium.
  • Ngatchou W; COVID-19 Working Group, Laquintinie Hospital, Douala, Cameroon; Department of Surgery and Specialities, Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Cameroon. Electronic address: willyngatchou@yahoo.fr.
Travel Med Infect Dis ; 47: 102292, 2022.
Article in English | MEDLINE | ID: covidwho-1747538
ABSTRACT

BACKGROUND:

Despite being a global pandemic, little is known about the factors influencing in-hospital mortality of COVID-19 patients in sub-Saharan Africa. This study aimed to provide data on in-hospital mortality among COVID-19 patients hospitalized in a single large center in Cameroon.

METHODS:

A hospital-based prospective follow-up was conducted from March 18 to June 30, 2020, including patients >18 years with positive PCR for SARS-COV-2 on nasopharyngeal swab admitted to the Laquintinie Douala hospital COVID unit. Predictors of in-hospital mortality were assessed using Kaplan Meir survival curves and Weibull regression for the accelerated time failure model. Statistical significance was considered as p < 0.05.

RESULTS:

Overall 712 patients (65,7% men) were included, mean age 52,80 ± 14,09 years. There were 580 (67,8% men) in-hospital patients. The median duration of hospital stay was eight days. The in-hospital mortality was 22.2%. Deceased patients compared to survivors were significantly older, had a higher temperature, respiratory rate, and heart rate, and lowest peripheral oxygen saturation at admission. After adjusting for age, sex, and other clinical patient characteristics, increased heart rate, increased temperature, decreased peripheral oxygen saturation. The critical clinical status was significantly associated with increased in-hospital mortality. In contrast, hospitalization duration greater than eight days and the use of hydroxychloroquine (HCQ) + azithromycin (AZM) therapy was associated with decreased risk of in-hospital mortality.

CONCLUSION:

One in five hospitalized COVID-19 patients die in a low-middle income setting. Critical clinical status, dyspnea, and increased heart rate were predictors of in-hospital mortality. This study will serve as a prerequisite for more robust subsequent follow-up studies. Also, these results will aid in revising national guidelines for the management of COVID-19 in Cameroon.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Female / Humans / Male / Infant, Newborn Country/Region as subject: Africa Language: English Journal: Travel Med Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: J.tmaid.2022.102292

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Female / Humans / Male / Infant, Newborn Country/Region as subject: Africa Language: English Journal: Travel Med Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: J.tmaid.2022.102292